Polyurethane-Coated Implants Reduce Complications After Breast Cancer Surgery
A groundbreaking European study has found that polyurethane-coated breast implants significantly lower the risk of complications for women undergoing reconstructive surgery after a mastectomy, particularly when followed by radiotherapy. The research, presented at the European Breast Cancer Conference in Barcelona, offers crucial evidence to guide treatment planning for patients likely to require radiation therapy.
Study Details and Key Findings
European scientists investigated approximately 1,500 women across 15 countries who were treated for breast cancer between 2016 and 2024. All participants had a mastectomy, followed by breast reconstruction with an implant and subsequent radiotherapy. Among them, one-third received polyurethane-coated implants, while just under 1,000 had standard silicone implants without the coating.
The study tracked the women's health for two-and-a-half to three years. Preliminary results showed that those with polyurethane-coated implants were significantly less likely to develop capsular contracture, a condition where hard, painful scar tissue forms around the implant. Specifically, 32.8% of women with coated implants experienced this issue, compared to 47.5% of those with standard implants.
Additionally, patients with polyurethane-coated implants had a reduced need for secondary surgery to remove scar tissue and a lower incidence of major infections in the breast. Dr Kerstin Wimmer, a surgeon at the Medical University of Vienna, stated: "Our study suggests that women who received polyurethane-coated implants had far fewer problems after radiotherapy than those who received standard implants."
Impact on Patient Care and Quality of Life
In the UK, about 55,000 women are diagnosed with breast cancer annually, with roughly 30% undergoing a mastectomy. Many of these women opt for reconstructive surgery, but radiotherapy can increase the risk of complications, such as scarring and infections. This study provides vital real-world evidence that implant type can influence these risks.
Prof Isabel Rubio, Head of Breast Surgical Oncology at the Clínica Universidad de Navarra in Madrid, emphasised the findings' potential to enhance patient comfort and aesthetic outcomes. "As we continue to move towards more personalised breast cancer care, evidence like this is valuable in guiding implant selection and treatment planning," she said. "The ultimate goal is not only to treat the cancer effectively, but also to minimise long-term side effects and enhance recovery for patients."
Catherine Priestley, senior clinical nurse specialist at Breast Cancer Now, highlighted the importance of comparing implant compatibility with radiotherapy. "It can help women make more informed and personalised choices, helping them to live better following breast cancer treatment," she noted, adding that further procedures can be emotionally and physically challenging for patients adjusting to treatment or body changes.
Future Directions and Expert Opinions
The polyurethane-coated implants consist of silicone with a spongy outer layer made of polyurethane, which appears to reduce scarring and infection rates. Dr Wimmer added that the implant type "may have a major impact on the risk of complications after radiotherapy," underscoring the study's role in reconstructive planning.
Sarah Downey, president of the Association of Breast Surgery, commented: "Breast implants continue to be an important option for many patients undergoing reconstruction, which can help to restore confidence and offer the potential for an improved quality of life. We look forward to further research in this area."
This research marks a significant step forward in breast cancer care, offering hope for reduced complications and better recovery outcomes for women worldwide.
